Chemoinformaics analysis of 1H-Pyrrole, 1-pentyl-
| Molecular Weight | 137.226 | nRot | 4 |
| Heavy Atom Molecular Weight | 122.106 | nRig | 5 |
| Exact Molecular Weight | 137.12 | nRing | 1 |
| Solubility: LogS | -2.901 | nHRing | 1 |
| Solubility: LogP | 3.241 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 5 |
| nHA | 1 | APOL | 26.1319 |
| nHD | 0 | BPOL | 16.7581 |
| QED | 0.562 |
| Synth | 2.046 |
| Natural Product Likeliness | -0.906 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.398 |
| HIA | 0.005 |
| CACO-2 | -4.15 |
| MDCK | 0.000032 |
| BBB | 0.833 |
| PPB | 0.414934 |
| VDSS | 2.57 |
| FU | 0.532515 |
| CYP1A2-inh | 0.99 |
| CYP1A2-sub | 0.636 |
| CYP2c19-inh | 0.947 |
| CYP2c19-sub | 0.07 |
| CYP2c9-inh | 0.589 |
| CYP2c9-sub | 0.088 |
| CYP2d6-inh | 0.847 |
| CYP2d6-sub | 0.083 |
| CYP3a4-inh | 0.477 |
| CYP3a4-sub | 0.233 |
| CL | 11.432 |
| T12 | 0.774 |
| hERG | 0.059 |
| Ames | 0.455 |
| ROA | 0.387 |
| SkinSen | 0.846 |
| Carcinogencity | 0.363 |
| EI | 0.973 |
| Respiratory | 0.154 |
| NR-Aromatase | 0.186 |
| Antiviral | No |
| Prediction | 0.936259 |